Skip to Content

Filter by:

Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.


Future innovations in health care and prevention require research across a full spectrum of biomedical science, from basic and translational research to implementation science and comparative effectiveness research. 

AAMC advocates for funding and appropriate regulation by major federal agencies and organizations supporting this research, including the National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), and the Department of Veterans Affairs (VA).

Ensuring a sustainable research mission is essential to achieve long-term health priorities, develop new therapeutics and preventive measures, focus on patient-centered outcomes, and reduce health disparities. 

We also work to ensure the integrity of biomedical research, especially research involving human subjects, including privacy protections and management of financial conflicts of interest.


Responsible Conduct of Research
Research with AnimalsStem Cell Research and Regenerative Medicine

News and Updates

Federal Officials Discuss Fiscal Year 2019 Biodefense and Preparedness Programs with House Appropriators

April 20, 2018

The House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies April 18 held a hearing to discuss the administration’s fiscal year (FY) 2019 budget proposal related to biodefense and preparedness programs at the Department of Health and Human Services (HHS).

HHS Proposes a Further Delay to the Common Rule

April 20, 2018

The U.S. Department of Health and Human Services (HHS) and 16 other federal departments and agencies April 19 issued a Notice of Proposed Rulemaking (NPRM) to delay the general compliance date for the revised Federal Policy for the Protection of Human Subjects (“the Common Rule”) for an additional six months, from July 19, 2018, to January 21, 2019, to “provide additional time to regulated entities for the preparations necessary to implement the 2018 requirements.”

CMS Report Shows Racial, Ethnic Quality and Satisfaction Disparities Persist among Medicare Advantage Beneficiaries

April 13, 2018

In collaboration with the RAND Corporation, the Centers for Medicare and Medicaid Services (CMS) April 11 released the 2018 Racial, Ethnic, and Gender Disparities in Health Care in Medicare Advantage report.

National Academies Recommends Dedicated Funding, Support for Next Generation Researchers

April 13, 2018

The National Academy of Sciences, Engineering, and Medicine (NASEM) April 12 released a new congressionally-mandated report stemming from the Next Generation Researchers Act and the 21st Century Cures Act [see Washington Highlights, September 11, 2015].

AAMC Submits Comments on the NIH’s Strategic Plan for Data Science

April 13, 2018

The AAMC April 2 submitted comments to the National Institutes of Health (NIH) in response to a request for information (RFI) on the agency’s first Strategic Plan for Data Science.

On Government Affairs

Research Spectrum

Testimony and Correspondence